$827.72
-15.75
(-1.87%)
As of Sep 5, 2026, 9:13 AM EDT
Price history
Regeneron Pharmaceuticals (REGN) is trading down at $827.72 (-1.87%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Recent News
No recent news mentioning Regeneron Pharmaceuticals in our feed yet.
More Health Care stocks
- ABBV AbbVie
- AMGN Amgen
- BIIB Biogen
- GILD Gilead Sciences
- INCY Incyte
- MRNA Moderna
- VRTX Vertex Pharmaceuticals
- A Agilent Technologies